Polo-like kinase 2: a new exploitable target to undermine mutant p53-dependent chemoresistance

Cell Cycle. 2012 Feb 1;11(3):438. doi: 10.4161/cc.11.3.19225. Epub 2012 Feb 1.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • DNA Damage / physiology*
  • Feedback, Physiological / physiology*
  • Gene Expression Regulation, Neoplastic / physiology*
  • Humans
  • Neoplasms / metabolism*
  • Protein Serine-Threonine Kinases / metabolism*
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Tumor Suppressor Protein p53
  • Protein Serine-Threonine Kinases